SG Americas Securities LLC acquired a new stake in Utah Medical Products, Inc. (NASDAQ:UTMD – Free Report) in the fourth quarter, Holdings Channel.com reports. The fund acquired 2,552 shares of the medical instruments supplier’s stock, valued at approximately $157,000.
Several other hedge funds have also made changes to their positions in UTMD. Copeland Capital Management LLC acquired a new stake in shares of Utah Medical Products during the third quarter valued at about $53,000. BNP Paribas Financial Markets raised its holdings in Utah Medical Products by 102.7% in the third quarter. BNP Paribas Financial Markets now owns 1,117 shares of the medical instruments supplier’s stock valued at $75,000 after acquiring an additional 566 shares in the last quarter. Virtu Financial LLC purchased a new stake in shares of Utah Medical Products during the 3rd quarter worth $207,000. GSA Capital Partners LLP acquired a new position in shares of Utah Medical Products during the 3rd quarter worth about $231,000. Finally, Martingale Asset Management L P boosted its holdings in Utah Medical Products by 5.3% in the third quarter. Martingale Asset Management L P now owns 3,968 shares of the medical instruments supplier’s stock valued at $266,000 after purchasing an additional 201 shares in the last quarter. Hedge funds and other institutional investors own 69.60% of the company’s stock.
Utah Medical Products Stock Down 0.1 %
NASDAQ UTMD opened at $59.85 on Monday. The business’s 50-day moving average price is $62.04 and its 200 day moving average price is $64.99. The firm has a market cap of $202.89 million, a P/E ratio of 15.15 and a beta of 0.08. Utah Medical Products, Inc. has a 52-week low of $58.87 and a 52-week high of $77.33.
Utah Medical Products Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Thursday, April 3rd. Stockholders of record on Friday, March 14th will be paid a dividend of $0.305 per share. The ex-dividend date of this dividend is Friday, March 14th. This represents a $1.22 dividend on an annualized basis and a dividend yield of 2.04%. Utah Medical Products’s dividend payout ratio (DPR) is presently 30.89%.
Wall Street Analysts Forecast Growth
Separately, StockNews.com lowered Utah Medical Products from a “strong-buy” rating to a “buy” rating in a report on Thursday, November 7th.
Check Out Our Latest Research Report on UTMD
Utah Medical Products Profile
Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.
Recommended Stories
- Five stocks we like better than Utah Medical Products
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- 3 Volatility ETFs to Help You Profit from Market Chaos
- Consumer Staples Stocks, Explained
- Lam Research: Is a NAND Upgrade Cycle the Next Growth Catalyst?
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Chipotle’s Slip: A Short-Term Dip or Long-Term Opportunity?
Want to see what other hedge funds are holding UTMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Utah Medical Products, Inc. (NASDAQ:UTMD – Free Report).
Receive News & Ratings for Utah Medical Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Utah Medical Products and related companies with MarketBeat.com's FREE daily email newsletter.